- Global Pharma News & Resources


Research & Development

bioeq GmbH is active in the development of biosimilar drugs for global markets in compliance with the stringent quality standards required for approval and distribution in the EU, US and other highly regulated countries. Therefore quality platforms according to current GCP and GMP standards are established.